Platelet-rich Plasma (PRP) in
Orthopaedics and Traumatology
By Dr Atanu Kayal, 2nd year PGT(ORTHOPAEDICS)
BURDWAN MEDICAL COLLEGE AND HOSPITAL.
WHAT IS PLATELET-RICH PLASMA
 Platelet-rich plasma (PRP)
is VOLUME OF PLASMA THAT HAS
A PLATELET COUNT ABOVE THE
BASELINE OF WHOLE BLOOD
 This works for offering an ''ideal
environment'' for tissue
regeneration and so-called
biological therapy.
 PRP was introduced in the 1950s .
 First used in 1987(open heart
surgery).
Platelet
functions
 Main role in Coagulation
Cascade pathway.
 Growth factors released
from platelets includes..
PDGF, TGF-B, VEGF, IGF-1,
EGF, ETGF, FGF-2 etc.
 Proposed function of PRP
 increase ECM deposition
 reduce pro-apoptotic
signals
 minimize joint
inflammation
Principles and Methods of Preparation of
Platelet-Rich Plasma
• PRP are four types according to
leukocytes and fibrin contents..
Type 1: leukocytes rich PRP
Type 2: leukocytes reduced
Type 3:fibrin rich PRP
Type 4: leukocytes fibrin rich PRP.
• PRP preparation methods..
PLASMA BASED PRP
OR
BUFFY COAT BASED PRP
PRP MECHANISM OF ACTION......
Current Clinical Applications of PRP
•OA KNEE grade 1-2
•EPICONDYLITIS
•ROTATOR CUFF TEARS
•PLANTAR FASCITIS
•MENISCUS REPAIR
•TENDONITIS
•LIGAMENTS SURGERY
PRP application Technique.........
EPICONDYLITIS.....
ACCELERATE HEALING IN ACHILLES
TENDON RUPTURES
HOW TO USE???
 2 injections for every
4-7 days and follow up
after 2-6 weeks to
examine pain/function
 Lignocaine deactivates
alfa granules because
of decrease pH value..
so avoid
 Ultrasound imaging
used to ensure a safe
and precise placement
PRP CONTRAINDICATIONS
ABSOLUTE
PLATELET DYSFUNCTION
SYNDROME
CRITICAL THROMBOCYTOPNEA
HEMODYNAMIC INSTABILITY
SEPTICEMIA
LOCAL INFECTION AT PROCEDURE
SITE
RELATIVE
CONSISTENT USE OF NSAIDS
WITHIN 48 HORS OF PROCEDURE
SYSTEMIC CORTICOSTEROIDS
WITHIN 2 WEEKS
TOBACCO USE
LATELET COUNT < 105/ul
Hemoglobin <10
Cancer Patients
PLATELET RICH PLASMA VS
CORTICOSTEROIDS INJECTION in the Treatment of
Plantar Fasciitis
VAS score in PRP group,
difference was maximum at 24 weeks and in the steroid
group, it was at 12 weeks.
• visual analog scale (VAS)
FAAM scores shows that maximum
effect of PRP on FAAM score was at 24 weeks whereas in
steroid group, it was at 12 weeks
• foot and ankle ability measure
• (FAAM) scores.
THANK YOY

Platelet rich plasma

  • 1.
    Platelet-rich Plasma (PRP)in Orthopaedics and Traumatology By Dr Atanu Kayal, 2nd year PGT(ORTHOPAEDICS) BURDWAN MEDICAL COLLEGE AND HOSPITAL.
  • 2.
    WHAT IS PLATELET-RICHPLASMA  Platelet-rich plasma (PRP) is VOLUME OF PLASMA THAT HAS A PLATELET COUNT ABOVE THE BASELINE OF WHOLE BLOOD  This works for offering an ''ideal environment'' for tissue regeneration and so-called biological therapy.  PRP was introduced in the 1950s .  First used in 1987(open heart surgery).
  • 3.
    Platelet functions  Main rolein Coagulation Cascade pathway.  Growth factors released from platelets includes.. PDGF, TGF-B, VEGF, IGF-1, EGF, ETGF, FGF-2 etc.  Proposed function of PRP  increase ECM deposition  reduce pro-apoptotic signals  minimize joint inflammation
  • 4.
    Principles and Methodsof Preparation of Platelet-Rich Plasma • PRP are four types according to leukocytes and fibrin contents.. Type 1: leukocytes rich PRP Type 2: leukocytes reduced Type 3:fibrin rich PRP Type 4: leukocytes fibrin rich PRP. • PRP preparation methods.. PLASMA BASED PRP OR BUFFY COAT BASED PRP
  • 5.
    PRP MECHANISM OFACTION......
  • 6.
    Current Clinical Applicationsof PRP •OA KNEE grade 1-2 •EPICONDYLITIS •ROTATOR CUFF TEARS •PLANTAR FASCITIS •MENISCUS REPAIR •TENDONITIS •LIGAMENTS SURGERY
  • 7.
  • 8.
    HOW TO USE??? 2 injections for every 4-7 days and follow up after 2-6 weeks to examine pain/function  Lignocaine deactivates alfa granules because of decrease pH value.. so avoid  Ultrasound imaging used to ensure a safe and precise placement
  • 9.
    PRP CONTRAINDICATIONS ABSOLUTE PLATELET DYSFUNCTION SYNDROME CRITICALTHROMBOCYTOPNEA HEMODYNAMIC INSTABILITY SEPTICEMIA LOCAL INFECTION AT PROCEDURE SITE RELATIVE CONSISTENT USE OF NSAIDS WITHIN 48 HORS OF PROCEDURE SYSTEMIC CORTICOSTEROIDS WITHIN 2 WEEKS TOBACCO USE LATELET COUNT < 105/ul Hemoglobin <10 Cancer Patients
  • 10.
    PLATELET RICH PLASMAVS CORTICOSTEROIDS INJECTION in the Treatment of Plantar Fasciitis VAS score in PRP group, difference was maximum at 24 weeks and in the steroid group, it was at 12 weeks. • visual analog scale (VAS) FAAM scores shows that maximum effect of PRP on FAAM score was at 24 weeks whereas in steroid group, it was at 12 weeks • foot and ankle ability measure • (FAAM) scores.
  • 11.